Related Experiment Videos
Lead poisoning treated with haemodialysis
Scandinavian Journal of Urology and Nephrology
|January 1, 1978
Summary
A woman experienced mild acute lead poisoning after ingesting litharge (PbO) as an abortifacient. Combined chelation therapy with EDTA and hemodialysis significantly reduced lead
Area of Science:
- Toxicology
- Environmental Health
- Pharmacology
Background:
- Lead (Pb) poisoning can occur through various routes, including intentional ingestion.
- Litharge (PbO) is a toxic form of lead compound.
- Acute lead intoxication requires prompt and effective medical intervention.
Observation:
- A 27-year-old woman intentionally ingested 40 grams of litharge (PbO).
- The patient presented with symptoms of acute lead intoxication, which were relatively mild.
- Treatment involved ethylenediaminetetraacetic acid (EDTA) infusion and hemodialysis.
Findings:
- The half-life of lead in the blood was significantly reduced during combined therapy.
- Combined hemodialysis and EDTA infusion resulted in a lead half-life of 9 hours.
- EDTA infusion alone yielded a lead half-life of 96 hours, indicating slower elimination.
Implications:
- Combined chelation therapy and hemodialysis are highly effective in accelerating lead elimination.
- This case highlights the critical role of timely and aggressive treatment in managing acute lead poisoning.
- Understanding lead pharmacokinetics is crucial for optimizing treatment strategies in heavy metal poisoning.